MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions

MARIETTA, Ga., Nov. 1, 2017 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts a... Devices, Regenerative Medicine, Wound Care, Litigation MiMedx, Halo Wound Solutions
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news